In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds
- PMID: 11751138
- PMCID: PMC126985
- DOI: 10.1128/AAC.46.1.220-224.2002
In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds
Abstract
Ertapenem, imipenem, meropenem, ceftriaxone, piperacillin, piperacillin-tazobactam, clindamycin, and metronidazole were agar dilution MIC tested against 431 anaerobes. Imipenem, meropenem, and ertapenem were the most active beta-lactams (MICs at which 50% of the strains are inhibited [MIC(50)s], 0.125 to 0.25 microg/ml; MIC(90)s, 1.0 to 2.0 microg/ml). Time-kill studies revealed that ertapenem at two times the MIC was bactericidal for 9 of 10 strains after 48 h. The kinetics for other beta-lactams were similar to those of ertapenem.
References
-
- Fuchs, P. C., A. L. Barry, and S. D. Brown. 1999. In-vitro antimicrobial activity of a carbapenem, MK-826 (L-749,345) and provisional interpretive criteria for disc tests. J. Antimicrob. Chemother. 43:703–706. - PubMed
-
- Jacobs, M. R., S. K. Spangler, and P. C. Appelbaum. 1990. β-Lactamase production, β-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres. J. Antimicrob. Chemother. 26:361–370. - PubMed
-
- National Committee for Clinical Laboratory Standards. 1997. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 4th ed. Approved standard. NCCLS publication no. M11–A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases